Moreover, the mode of action of the R‐Tf‐D‐LP4 peptide explains why it is not directed to a specific cancer type but rather acts on a variety of cancers, regardless of the mutations involved or the survival mechanisms acquired. This evidence concerns the gene TF and cancer.